Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2018 R21 RFA-CA-17-010 SCHIBEL, ANNA ELECTRONIC BIOSCIENCES, INC. Microsatellite Sequencing to Enable Cancer Genotyping Complete
2022 R21 CA21-003 ARMITAGE, BRUCE A CARNEGIE-MELLON UNIVERSITY Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA Active
1999 R21 PAR-98-067 MEYER, TOBIAS DUKE UNIVERSITY CELL ARRAYS FOR SCREENING SIGNAL TRANSDUCTION PROCESSES Complete
2004 R21 PAR-01-106 SIMS, CHRISTOPHER E UNIVERSITY OF CALIFORNIA IRVINE ASSAYING TYROSINE KINASE ACTIVITY: A NEW PARADIGM Complete
2007 R21 RFA-CA-07-015 WANG, NICHOLAS J UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB NANO-SCALE DETECTION OF THE DISEASE PROTEOME Complete
2010 R21 RFA-CA-09-008 BARRETT, MICHAEL T TRANSLATIONAL GENOMICS RESEARCH INST HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES Complete
2014 R21 RFA-CA-13-001 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE INTEGRATED MICROFLUIDIC EXOSOME PROFILING FOR EARLY DETECTION OF CANCER Complete
2017 R21 RFA-CA-16-001 SOELLNER, MATTHEW B UNIVERSITY OF MICHIGAN AT ANN ARBOR Exquisitely selective turn-on probes of kinase activation and localization Complete
2021 R21 RFA-CA-20-017 BAR-PELED, LIRON MASSACHUSETTS GENERAL HOSPITAL Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors Active
2001 R21 PAR-99-100 WATT, PAUL M TELETHON INSTITUTE FOR CHILD HEALTH RES MECHANISMS OF GENOMIC INSTABILITY IN CANCER Complete
2003 R21 PAR-01-106 LABAER, JOSHUA HARVARD UNIVERSITY (MEDICAL SCHOOL) FUNCTIONAL PROTEOMICS OF BREAST CANCER Complete
2009 R21 RFA-CA-08-007 TYCKO, BENJAMIN COLUMBIA UNIVERSITY HEALTH SCIENCES OPTIMIZING MSNP FOR PROFILING DNA METHYLATION IN CANCERS AND PRECURSOR LESIONS Complete
2013 R21 RFA-CA-13-001 CHENG, JI-XIN PURDUE UNIVERSITY QUANTITATIVE SPECTROSCOPIC IMAGING OF CANCER METABOLITES IN LIVE CELLS AND INTACT Complete
2016 R21 RFA-CA-15-004 SULCHEK, TODD GEORGIA INSTITUTE OF TECHNOLOGY LABEL-FREE MICROFLUIDIC ENRICHMENT OF CANCER CELLS FROM NONCANCER CELLS IN ASCITES FLUID Complete
2006 R21 RFA-CA-06-002 TOLLEY, LUKE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE DEVELOPMENT OF DYNAMIC ISOELECTRIC FOCUSING FOR CANCER PROTEOMICS Complete
2019 R21 RFA-CA-18-002 WEISSLEDER, RALPH MASSACHUSETTS GENERAL HOSPITAL Single Circulating Vesicle Analysis for Early Cancer Detection Complete
2000 R21 PAR-98-067 GAO, XIAOLIAN UNIVERSITY OF HOUSTON PARALLEL SYNTHESIS OF RNA OLIGONUCLEOTIDE MICROARRAYS Complete
2002 R21 PAR-01-106 CHUONG, CHENG-MING UNIVERSITY OF SOUTHERN CALIFORNIA HIGH RESOLUTION MICROARRAY ANALYSIS OF CANCER Complete
2005 R21 RFA-CA-05-002 CHIOCCA, E. ANTONIO OHIO STATE UNIVERSITY IMAGING TRANSCRIPTIONAL ACTIVATION OF GLIOMAS Complete
2008 R21 RFA-CA-07-033 REHEMTULLA, ALNAWAZ UNIVERSITY OF MICHIGAN HTS FOR FADD KINASE INHIBITORS USING MOLECULAR IMAGING Complete
2011 R21 RFA-CA-10-003 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS APPLICATION OF AN INNOVATIVE TECHNOLOGY TO DEVELOP LOW TOXICITY KINASE INHIBITORS Complete
2015 R21 RFA-CA-14-003 LABAER, JOSHUA ARIZONA STATE UNIVERSITY-TEMPE CAMPUS MULTIPLEXED IN SOLUTION PROTEIN ARRAY (MISPA) FOR IDENTIFYING NOVEL PROTEIN INTERACTIONS IN CANCER AND FOR EARLY DETECTION OF IMMUNE RESPONSES IN PATHOGEN-INDUCED CANCERS Complete
2018 R21 RFA-CA-17-010 SHI, TUJIN BATTELLE PACIFIC NORTHWEST LABORATORIES An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells Complete
2022 R21 CA21-003 COUNTER, CHRISTOPHER M DUKE UNIVERSITY Adapting K-MDS to detect KRAS-mutant ctDNA Active
2004 R21 PAR-01-106 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS Complete
2007 R21 RFA-CA-07-017 XU, BAOGANG JONATHAN VANDERBILT UNIVERSITY MED CTR IDENTIFICATION OF BREAST TUMOR SECRETOME CHANGES THROUGHOUT TUMOR PROGRESSION Complete
2010 R21 RFA-CA-09-008 RIETHMAN, HAROLD WISTAR INSTITUTE TECHNOLOGY FOR DETECTION AND QUANTITATION OF TELOMERIC DNA ABERRATIONS IN CANCER Complete
2014 R21 RFA-CA-13-001 CHEN, XIAOWEI RESEARCH INST OF FOX CHASE CAN CTR A NOVEL ALLELE-SPECIFIC RNA-ISH FOR DIFFERENTIAL ALLELE-SPECIFIC EXPRESSION Complete
2017 R21 RFA-CA-16-001 SLATER, JOHN HUNDLEY UNIVERSITY OF DELAWARE A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases Complete
2021 R21 RFA-CA-20-017 CHEN, KAI UNIVERSITY OF SOUTHERN CALIFORNIA Novel Bisphosphonate PET Probes for Myeloma Bone Disease Active
2001 R21 PAR-99-100 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY STUDIES OF HEMATOLOGIC MALIGNANCIES BY PNA TECHNOLOGY Complete
2003 R21 PAR-01-106 ANGELETTI, RUTH HOGUE YESHIVA UNIVERSITY PROTEOMICS OF HEPATIC CARCINOGENESIS Complete
2009 R21 RFA-CA-08-007 WATERMAN, MARIAN L UNIVERSITY OF CALIFORNIA-IRVINE LEF-1 TRANSLATION IN CHRONIC MYELEGENOUS LEUKEMIA Complete
2013 R21 RFA-CA-13-001 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE LECTIMERS: GLYCAN-ANCHORED SCAFFOLD LIBRARIES FOR TARGETING CARBOHYDRATE-BINDING Complete
2016 R21 RFA-CA-15-004 VANDER GRIEND, DONALD JAMES UNIVERSITY OF CHICAGO SUPRAMOLECULAR MATRIX MATERIALS FOR PROSTATE CANCER CELL BIOLOGY Complete
2006 R21 RFA-CA-06-002 WELSH, JOHN T SIDNEY KIMMEL CANCER CENTER CANCER VERTICAL ARRAYS Complete
2019 R21 RFA-CA-18-002 GARBER, MANUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER A modular; customizable sequencing system for simultaneous genotyping and transcript analysis in single cells Complete
2000 R21 PAR-98-067 BENNETT, SCOTT W SRA INTERNATIONAL, INC. INNOVATIVE ALGORITHMS FOR MICROARRAY ANALYSIS Complete
2002 R21 PAR-01-106 LEVENSON, VICTOR V NORTHWESTERN UNIVERSITY DNA METHYLATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA Complete
2005 R21 RFA-CA-05-002 BOGDANOV, ALEXEI A UNIV OF MASSACHUSETTS MED SCH WORCESTER TRANSCRIPTION FACTOR REPORTER TECHNOLOGY Complete
2008 R21 RFA-CA-07-033 MUDDIMAN, DAVID C. NORTH CAROLINA STATE UNIVERSITY RALEIGH IMPROVED CANCER BIOMARKER DETECTION USING NOVEL AIR AMPLIFIER DESIGNS IN ESI-MS Complete
2011 R21 RFA-CA-10-003 HARISMENDY, OLIVIER UNIVERSITY OF CALIFORNIA SAN DIEGO IDENTIFICATION OF SOMATIC MUTATIONS IN RARE SUBCLONES OF SOLID TUMORS Complete
2015 R21 RFA-CA-14-003 ANDERSON, KAREN SUE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS SINGLE CELL TECHNOLOGIES FOR RAPID DETECTION OF TUMOR HETEROGENEITY Complete
2018 R21 RFA-CA-17-010 SMITH, LLOYD M UNIVERSITY OF WISCONSIN-MADISON Novel NeuCode Tagging Reagents for Identification and Quantification of Intact Proteoforms in Cancer Tissues Complete
2004 R21 PAR-01-106 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON SINGLE CELL PROTEIN FINGERPRINTING - BARRETT'S ESOPHAGUS Complete
2007 R21 RFA-CA-07-019 NILSEN-HAMILTON, MARIT IOWA STATE UNIVERSITY DRUGCARTS TO COMBAT DRUG RESISTANCE Complete
2010 R21 RFA-CA-09-008 CHILES, THOMAS C. BOSTON COLLEGE A NOVEL NANOCOAXIAL BIOSENSOR FOR DETECTION OF CANCER BIOMARKERS Complete
2014 R21 RFA-CA-13-001 LEVENSON, RICHARD M. UNIVERSITY OF CALIFORNIA AT DAVIS HIGHLY MULTIPLEXED ION-BEAM TISSUE RNA IN SITU IMAGING WITH SUB-MICRON RESOLUTION Complete
2017 R21 RFA-CA-16-001 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA A novel time-resolved fluorescence-based high-throughput screening technology for discovering allosteric kinase inhibitors Complete
2017 R21 RFA-CA-16-003 NECHAEV, SERGEI UNIVERSITY OF NORTH DAKOTA Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments. Complete

Pages